Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44334 clinical trials with a EudraCT protocol, of which 7366 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (44,334)
Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)

44,334 result(s) found. Displaying page 236 of 2,217.

EudraCT Number: 2013-002066-39	Sponsor Protocol Number: REPEXStudy	Start Date*: 2013-09-04
Sponsor Name:Azienda Ospedaliera di Reggio Emilia Arcispedale "S.Maria Nuova"/IRCCS
Full Title: The Reggio Emilia study on bromfenac for patients with PseudoEXfoliation syndrome undergoing cataract surgery: the REPEX study
Medical condition: Postoperative inflammation in patients with pseudoexfoliatio lentis undergoing cataract surgery
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: (No results available)

EudraCT Number: 2013-002094-22

Sponsor Protocol Number: 2013MM002B

Start Date*: 2013-08-29

Sponsor Name:Royal Brompton and Harefield NHS Foundation Trust (RB&HFT)

Full Title: Comparison of ultra-low-dose Oral versus Transdermal Hormone Therapy on coagulation activation and metabolic risk factors for Cardiovascular Disease

Medical condition: The effect of oestrogen replacement therapy taken either orally or transdermally and observing any likely benefit of both these therapies on the risks Venous thromobembolic events and cardiovascul...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	16.1	10038604 - Reproductive system and breast disorders	10027309	Menopause and related conditions	HLGT

Population Age: Adults

Gender: Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2013-002116-27

Sponsor Protocol Number: HMPL-004-03

Start Date*: 2013-10-28

Sponsor Name:Nutrition Science Partners Limited

Full Title: A Phase III, Randomized, Multi-Centre, Double-Blind, Placebo-Controlled Trial of HMPL-004 in Patients with Mild to Moderate Active Ulcerative Colitis (NATRUL-3)

Medical condition: Ulcerative Colitis (UC)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	17.0	100000004856	10045365	Ulcerative colitis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: LV (Prematurely Ended) HU (Prematurely Ended) LT (Prematurely Ended) CZ (Prematurely Ended) BG (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2010-023037-35

Sponsor Protocol Number: LIEPS2010

Start Date*: 2011-05-05

Sponsor Name:York Teaching Hospital NHS Foundation Trust

Full Title: Short-term intraocular pressure trends in high risk patients following intravitreal Ranibizumab (Lucentis) injections for Wet Age Related Macular Degeneration - Is there a role for systemic Acetazo...

Medical condition: Glaucoma and Glaucoma suspect

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10015919 - Eye disorders	10006028	Borderline glaucoma (glaucoma suspect)	LLT
	14.1	10015919 - Eye disorders	10018304	Glaucoma	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2011-001913-14	Sponsor Protocol Number: SSAT043	Start Date*: 2011-11-08
Sponsor Name:St Stephen's Aids Trust
Full Title: A randomized crossover study of the effects of zinc sulphate supplementation on atazanavir/ritonavir-associated hyperbilirubinemia
Medical condition: HIV
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results

EudraCT Number: 2011-001929-24	Sponsor Protocol Number: 1392-H-199	Start Date*: 2011-09-19
Sponsor Name:Fundación para la Investigación Biomédica del Hospital 12 de Octubre
Full Title: Randomised, open-label, crossover clinical trial to evaluate the antiproteinuric effect of three different types of diuretics (hydrochlorothiazide, amiloride and spironolactone) in patients with ch...
Medical condition: Chronic proteinuric nephropathies
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)

EudraCT Number: 2011-001935-21

Sponsor Protocol Number: 8-55-52133-010

Start Date*: 2011-08-30

Sponsor Name:IPSEN PHARMA SAS

Full Title: An interventional non-therapeutic study to assess ex vivo basophil activation in response to various preparations of taspoglutide and related items in blood samples from subjects who previously rec...

Medical condition: Diabetes

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10027433 - Metabolism and nutrition disorders	10012601	Diabetes mellitus	PT

Population Age: Adults, Elderly

Gender: Male

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2013-002986-21

Sponsor Protocol Number: MST-188-01

Start Date*: 2014-06-16

Sponsor Name:Mast Therapeutics, Inc.

Full Title: Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC): A Phase 3, Randomized, Double-Blind, Placebo-Controlled Multicenter Clinical Trial of MST-188 (purified ...

Medical condition: Sickle Cell Disease with Vaso-Occlusive Crisis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	18.0	100000004850	10040644	Sickle cell disease	LLT

Population Age: Children, Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed) ES (Completed)

Trial results: (No results available)

EudraCT Number: 2008-003766-26

Sponsor Protocol Number: 25-12-59

Start Date*: 2009-10-12

Sponsor Name:Southampton University Hospitals NHS Trust

Full Title: The effects of purified n-3 fatty acids on serum biomarkers and cardiovascular risk markers in a randomized placebo controlled trial in patients with non alcoholic fatty liver disease

Medical condition: Non alcoholic fatty liver disease (NAFLD). This fatty liver disease may progress to a chronic condition that sometimes deteriorates further to cirrhosis and even liver carcinoma. To date there is n...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10019805 - Hepatobiliary disorders	10031743	Other chronic nonalcoholic liver disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2012-003574-66

Sponsor Protocol Number: 34964

Start Date*: 2013-01-04

Sponsor Name:Ortopædkirurgisk Forskning - Aarhus Universitetshospita

Full Title: Osseointegrated transdermal femoral amputation prostheses - Denusomab Trial

Medical condition: leg amputee

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	16.0	10042613 - Surgical and medical procedures	10024124	Leg amputation	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Prematurely Ended)

Trial results: View results

EudraCT Number: 2013-001094-25

Sponsor Protocol Number: 200188

Start Date*: 2013-07-10

Sponsor Name:GlaxoSmithKline Biologicals

Full Title: A Phase III, open-label, non-randomised, multi-centre, single dose study to assess the immunogenicity and safety of GSK Biologicals' Quadrivalent Split Virion Influenza Vaccine (GSK2321138A) Influs...

Medical condition: Immunization of healthy adults against influenza

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	100000004865	10059430	Influenza immunization	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2012-005580-27

Sponsor Protocol Number: ONC-2011-005

Start Date*: 2013-04-06

Sponsor Name:ISTITUTO CLINICO HUMANITAS

Full Title: MULTI-CENTER, PHASE II STUDY TO ASSESS THE SAFETY AND EFFICACY OF HAPLOIDENTICAL BONE MARROW TRANSPLANTATION USING REDUCED INTENSITY CONDITIONING (RIC) REGIMEN AND POST-TRANSPLANT CYCLOPHOSPHAMIDE,...

Medical condition: Patients with lymphomas (any histology) relapsed after high dose chemotherapy and in complete remission or partial remission after the last CT line

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10003908	B-cell small lymphocytic lymphoma	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10003899	B-cell lymphoma	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10008958	Chronic lymphocytic leukaemia	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10012818	Diffuse large B-cell lymphoma	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10020206	Hodgkin's disease	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10034623	Peripheral T-cell lymphoma unspecified	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2012-005592-13

Sponsor Protocol Number: FERRICHFII

Start Date*: 2014-02-27

Sponsor Name:King's College London [...]

Full Title: Mechanisms of Exercise Benefit with Intravenous Iron in Chronic Heart Failure: The Ferric Iron in Heart Failure (FERRIC HF) II Trial

Medical condition: Chronic Heart Failure

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	18.0	100000004849	10008908	Chronic heart failure	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2013-001167-22	Sponsor Protocol Number: 43488	Start Date*: 2017-06-29
Sponsor Name:
Full Title: Spinal Morphine in laparoscopic gastro-intestinal surgery
Medical condition: Patients with indications for laparoscopic gastro-intestinal surgery
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2013-001192-21

Sponsor Protocol Number: BAY85-3934/15261

Start Date*: 2013-12-12

Sponsor Name:Bayer HealthCare AG

Full Title: A randomized, parallel group, open-label, multicenter study to investigate the efficacy and safety of oral BAY 85-3934 and active comparator (darbepoetin alfa) in the maintenance treatment of anemi...

Medical condition: Anaemia of Chronic Kidney Disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	18.1	100000004851	10058132	Renal anemia	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) HU (Completed) IT (Completed) ES (Completed) BG (Completed) PL (Completed)

Trial results: View results

EudraCT Number: 2013-001193-14

Sponsor Protocol Number: BAY85-3934/15141

Start Date*: 2013-12-11

Sponsor Name:Bayer HealthCare AG

Full Title: A randomized, placebo-controlled, double-blind, parallel group, multicenter study to investigate the efficacy and safety of 5 fixed doses of BAY 85- 3934 administered orally in the correction of an...

Medical condition: Anaemia of Chronic Kidney Disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	18.0	100000004851	10058123	Renal anaemia	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) IT (Completed) HU (Completed) BG (Completed) ES (Completed) PL (Completed)

Trial results: View results

EudraCT Number: 2013-001212-30	Sponsor Protocol Number: GW/MB/42964	Start Date*: 2013-07-04
Sponsor Name:
Full Title: Modulation of immune function by parenteral fish oil in patients with Crohn’s disease and high inherent Tumor Necrosis Factor-alfa production, a randomized, single blinded, cross-over study
Medical condition: Crohn's disease
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2012-000364-21

Sponsor Protocol Number: PI1102031

Start Date*: 2012-11-13

Sponsor Name:Fundació Clínic per a la Recerca Biomédica

Full Title: FDDNP-PET FOR IN VIVO DIAGNOSIS OF TAUOPATHY IN UNCLASSIFIABLE PARKINSONISM

Medical condition: Atypical Parkinsonism

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10029205 - Nervous system disorders	10034010	Parkinsonism	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2013-001564-37

Sponsor Protocol Number: AGMT_HIV1

Start Date*: 2013-12-02

Sponsor Name:Arbeitsgemeinschaft medikamentöse Tumortherapie gemeinnützige GmbH

Full Title: One arm, Open label, Interventional, non-comparative Study to assess Changes in Lipids and Lipoproteins in HIV infected Women with Hyperlipidemia after Switch from boosted Protease Inhibitors to Ra...

Medical condition: HIV

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	100000004862	10068341	HIV-1 infection	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: AT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2013-001584-22

Sponsor Protocol Number: VDM/032711

Start Date*: 2013-09-16

Sponsor Name:Gerolsteiner Brunnen GmbH & Co. KG

Full Title: Pilot study with St. Gero for heartburn

Medical condition: Functional dyspeptic complaints, particularly heartburn (at least 3 months prior to study start, at least twice per week)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	100000004856	10019326	Heartburn	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Thu May 01 06:26:42 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA